Supply of Infliximab or biosimilar

Our Lady's Children's Hospital, Crumlin

To appoint a single provider for the provision, supply, support and delivery of Infliximab or Infliximab biosimilar to patients in Our Lady’s Children’s Hospital Crumlin (OLCHC). It is envisaged that Infliximab-naive patients in OLCHC will receive the tendered product initially with a view to switch all existing patients within 6 months.

Deadline

The time limit for receipt of tenders was 2018-04-27. The procurement was published on 2018-04-20.

Suppliers

The following suppliers are mentioned in award decisions or other procurement documents:

• Pfizer Healthcare Ireland

Who?

• Our Lady's Children's Hospital, Crumlin

What?

• Medical equipments, pharmaceuticals and personal care products › Pharmaceutical products

Where?

• Éire/Ireland

Procurement history

Date	Document
2018-04-20	Contract notice
2018-09-26	Contract award notice

Contract notice (2018-04-20)
Object
Scope of the procurement
Title: Pharmaceutical products
Short description:
“To appoint a single provider for the provision, supply, support and delivery of Infliximab or Infliximab biosimilar to patients in Our Lady’s Children’s...”
Notice metadata
Original language: English 🗣️
Document type: Contract notice
Nature of contract: Supplies
Regulation: European Union
Common procurement vocabulary (CPV)
Code: Pharmaceutical products 📦
Additional CPV: Pharmaceutical products 📦
Place of performance
NUTS region: Éire/Ireland 🏙️

Procedure
Procedure type: Open procedure
Type of bid: Submission for all lots
Award criteria
The most economic tender

Contracting authority
Identity
Country: Ireland 🇮🇪
Awarding authority type: Body governed by public law
Awarding authority name: Our Lady's Children's Hospital, Crumlin
Postal address: Dublin 12
Postal code: Ireland
Postal town: Dublin
Contact
Internet address: http://www.olchc.ie 🌏
E-mail: robert.keogh@olhsc.ie 📧
Phone: +353 14096598 📞
URL for documents: http://irl.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=126683&B=ETENDERS_SIMPLE 🌏

Reference
Dates
Date dispatched: 2018-04-20 📅
Submission deadline: 2018-04-27 📅
Publication date: 2018-04-24 📅
Identifiers
Notice number: 2018/S 079-176043
OJ-S issue: 79

Object
Scope of the procurement
Estimated total value: 1 EUR 💰
Short description:
“To appoint a single provider for the provision, supply, support and delivery of Infliximab or Infliximab biosimilar to patients in Our Lady’s Children’s...”
Estimated value excluding VAT: 1 EUR 💰
Duration: 36 months
Description of renewals:
“The contract will be for an initial 12 month period with an option to extend to 36 months subject to satisfactory performance. The Hospital reserves the...”
Place of performance
Main site or place of performance:
“Our Lady's Children's Hospital, Crumlin”

Legal, economic, financial and technical information
Conditions for participation
Suitability to pursue the professional activity:
“Must be licensed for use in the Republic of Ireland (ROI) by the Health Products Regulatory Authority (HPRA).”

“Published data on the use of infliximab or biosimilar infliximab in the paediatric population must be supplied if applicable.”

Procedure
Time of receipt of tenders: 12:00
Languages in which tenders or requests to participate may be submitted: English 🗣️
Tender validity period: 36 months
Tender opening date: 2018-04-27 📅
Tender opening time: 12:00
Place: Our Lady's Children's Hospital, Crunlin

Contracting authority
Identity
National registration number: N/a
Contact
Contact point: robert keogh
Address of the buyer profile: https://irl.eu-supply.com/ctm/Company/CompanyInformation/Index/384 🌏
Documents URL: http://irl.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=126683&B=ETENDERS_SIMPLE 🌏

Complementary information
Review body
Name: High Court
Postal address: Inns Quay
Postal town: Dublin
Postal code: 7
Country: Ireland 🇮🇪
Source: OJS 2018/S 079-176043 (2018-04-20)

Contract award notice (2018-09-26)
Object
Scope of the procurement
Short description:
“To appoint a single provider for the provision, supply, support and delivery of Infliximab or Infliximab Biosimilar to patients in Our Lady’s Children’s...”
Total value of the procurement: 550 000 EUR 💰
Notice metadata
Document type: Contract award notice

Procedure
Type of bid: Not applicable

Reference
Dates
Date dispatched: 2018-09-26 📅
Publication date: 2018-09-27 📅
Identifiers
Notice number: 2018/S 186-420045
Refers to notice: 2018/S 079-176043
OJ-S issue: 186

Procedure
Award criteria
Quality criterion (name): Quality of Supply
Quality criterion (weighting): 20 %
Quality criterion (name): Quality and Fitness for Purpose
Value Add
Quality criterion (weighting): 15 %
Cost criterion (name): Overall Cost
Cost criterion (weighting): 45 %

Award of contract
Date of contract conclusion: 2018-08-17 📅
Name: Pfizer Healthcare Ireland
Postal address: 9 Riverwalk, National Digital Park
Postal town: Dublin
Postal code: 22
Country: Ireland 🇮🇪
Phone: +44 353526186000 📞
E-mail: caroline.reidy@pfizer.com 📧
Country: Dublin 🏙️
Information about tenders
Number of tenders received: 3

Contracting authority
Contact
Contact point: Robert Keogh
Source: OJS 2018/S 186-420045 (2018-09-26)

New procurements in related categories 🆕

Medical equipments, pharmaceuticals and personal care products (8 new procurements)

Pharmaceutical products (1)